mRNA’s Path Forward
April 4, 2024
Washington, D.C., USA
The Alliance for mRNA Medicines invites you to participate in a global summit focused on the most pressing regulatory issues impacting mRNA technologies.
At this summit, regulatory, industry, and academic leaders will present and discuss the
opportunities for harmonizing the regulatory framework for mRNA. The leaders will detail the
specific opportunities involving:
The summit offers a unique opportunity for meaningful knowledge exchange, discussion, and interaction between regulators and attendees on timely and relevant issues. Attendees will:
Head of Biological Health Threats and Vaccines Strategy
European Medicines Agency
Director
Center for Biologics Evaluation and Research (CBER)
Head of Biological Products
UK Medicines and Healthcare Products Regulatory Agency (MHRA)
Senior Medical Advisor, Pre-Market Assessment Branch
Australia Therapeutic Goods Administration
Senior Pharmaceutical Assessor
UK Medicines and Healthcare Products Regulatory Agency (MHRA)
Biologist/Evaluator
Health Canada
The Alliance for mRNA Medicines (AMM) is the leading global organization dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines for the benefit of patients, public health, and society. Our mission is to propel the future of mRNA medicine, improve patients’ lives, and advance scientific knowledge by convening and empowering the mRNA community, including industry leaders, innovators, scientists, and other key stakeholders.
8:00 AM – 8:30 AM ET
Networking Breakfast
8:30 AM – 8:45 AM ET
Welcome and Agenda Review
8:45 AM – 9:30 AM ET
Opening Fireside Chat: Setting the Stage
9:30 – 11:15 AM ET
Panel Discussion 1: Regulator Perspectives
11:15 AM – 11:30 AM
Coffee break
11:30 AM – 12:30 PM
Panel Discussion 2: Harmonization opportunities for mRNA as a platform
12:30 PM – 1:15 PM
Lunch
1:15 PM – 2:15 PM
Panel Discussion 3: Harmonization opportunities: mRNA Chemistry, Manufacturing and Controls
2:15 PM – 2:30 PM
Break
2:30 PM – 3:30 PM
Panel Discussion 4: Harmonization opportunities: mRNA delivery systems
3:30 PM – 4:00 PM
Reflections, Wrap Up, and Next Steps
4:00 PM
Reception